HUP0103460A2 - Vírusellenes hatású indolszármazékok és a vegyületeket tartalmazó gyógyszerkészítmények - Google Patents
Vírusellenes hatású indolszármazékok és a vegyületeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP0103460A2 HUP0103460A2 HU0103460A HUP0103460A HUP0103460A2 HU P0103460 A2 HUP0103460 A2 HU P0103460A2 HU 0103460 A HU0103460 A HU 0103460A HU P0103460 A HUP0103460 A HU P0103460A HU P0103460 A2 HUP0103460 A2 HU P0103460A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- optionally substituted
- indole derivatives
- hydrogen atom
- pharmaceutical compositions
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title abstract 2
- 229940054051 antipsychotic indole derivative Drugs 0.000 title abstract 2
- 150000002475 indoles Chemical class 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 102100034343 Integrase Human genes 0.000 abstract 1
- 108010061833 Integrases Proteins 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 230000036436 anti-hiv Effects 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/22—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
Abstract
A találmány tárgyát az integráz inhibitor hatású, így vírusellenes,különösen HIV-ellenes hatóanyagként hasznosítható általános képletűindolszármazékok - amely képletben előnyösen R1 hidrogénatom vagyadott esetben szubsztituált aril-szulfonilcsoport R2 hidrogénatom,adott esetben szubsztituált aril- vagy aralkilcsoport; R3, R4, R5 ésR6 hidrogén- vagy halogénatom; X hidroxi- vagy adott esetbenszubsztituált aminocsoport; és Y -COOR általános képletű csoport (aholR hidrogénatom vagy észtert képező csoport) vagy adott esetbenszubsztituált heteroarilcsoport - és gyógyszerészetileg elfogadhatósóik vagy hidrátjaik, valamint ezeket hatóanyagként tartalmazógyógyszerkészítmények képezik. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7820398 | 1998-03-26 | ||
PCT/JP1999/001547 WO1999050245A1 (fr) | 1998-03-26 | 1999-03-26 | Derives d'indole exerçant une activite antivirale |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0103460A2 true HUP0103460A2 (hu) | 2002-01-28 |
HUP0103460A3 HUP0103460A3 (en) | 2002-11-28 |
Family
ID=13655476
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0103460A HUP0103460A3 (en) | 1998-03-26 | 1999-03-26 | Indole derivatives with antiviral activity and pharmaceutical compositions containing them |
Country Status (17)
Country | Link |
---|---|
US (3) | US6333323B1 (hu) |
EP (1) | EP1069111A4 (hu) |
JP (1) | JP3794469B2 (hu) |
KR (1) | KR20010041705A (hu) |
CN (1) | CN1142909C (hu) |
AU (1) | AU752005B2 (hu) |
BR (1) | BR9909146A (hu) |
CA (1) | CA2326166A1 (hu) |
HU (1) | HUP0103460A3 (hu) |
ID (1) | ID26031A (hu) |
IL (1) | IL137974A0 (hu) |
NO (1) | NO317423B1 (hu) |
NZ (1) | NZ506435A (hu) |
PL (1) | PL343249A1 (hu) |
RU (1) | RU2217421C2 (hu) |
WO (1) | WO1999050245A1 (hu) |
ZA (1) | ZA200004047B (hu) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6142163A (en) * | 1996-03-29 | 2000-11-07 | Lam Research Corporation | Method and apparatus for pressure control in vacuum processors |
AU752005B2 (en) * | 1998-03-26 | 2002-09-05 | Shionogi & Co., Ltd. | Indole derivatives with antiviral activity |
EP1082121A4 (en) * | 1998-06-03 | 2003-02-05 | Merck & Co Inc | INTEGRASE HIV INHIBITORS |
CA2333771A1 (en) * | 1998-06-03 | 1999-12-09 | Mark W. Embrey | Hiv integrase inhibitors |
CZ20012160A3 (cs) | 1998-12-25 | 2001-10-17 | Shionogi & Co., Ltd. | Heteroaromatické deriváty s inhibiční aktivitou proti HIV integráze |
US7294481B1 (en) * | 1999-01-05 | 2007-11-13 | Immunex Corporation | Method for producing recombinant proteins |
TR200202129T2 (tr) | 1999-06-02 | 2003-03-21 | Shionogi & Co., Ltd. | Yeni ikameli propenon türevlerinin hazırlanması için prosesler. |
EP1196384A4 (en) * | 1999-06-25 | 2002-10-23 | Merck & Co Inc | 1- (AROMATIC OR HETEROAROMATICALLY SUBSTITUTED) -3- (HETEROAROMATICALLY SUBSTITUTED) -1,3-PROPANDIONS AND THEIR APPLICATIONS |
ATE504572T1 (de) * | 1999-09-02 | 2011-04-15 | Shionogi & Co | Derivate von aromatische heterocyclen enthaltende integraseinhibitoren |
RU2002135640A (ru) * | 2000-06-13 | 2004-05-10 | Шионоги Энд Ко., Лтд. (Jp) | Фармацевтические композиции, содержащие пропеноновые производные |
AU2001262732A1 (en) * | 2000-06-14 | 2001-12-24 | Shionogi And Co., Ltd. | Inhibitor for enzyme having two divalent metal ions as active centers |
US7144723B2 (en) * | 2000-11-16 | 2006-12-05 | The Regents Of The University Of California | Marine actinomycete taxon for drug and fermentation product discovery |
US7067539B2 (en) | 2001-02-08 | 2006-06-27 | Schering Corporation | Cannabinoid receptor ligands |
US7507767B2 (en) | 2001-02-08 | 2009-03-24 | Schering Corporation | Cannabinoid receptor ligands |
CA2439666A1 (en) | 2001-03-01 | 2002-09-12 | Shionogi & Co., Ltd. | Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity |
EP3042894A1 (en) | 2001-08-10 | 2016-07-13 | Shionogi & Co., Ltd. | Antiviral agent |
ITMI20012060A1 (it) * | 2001-10-05 | 2003-04-05 | Recordati Chem Pharm | Nuovi eterocilcli n-acilati |
DK1441735T3 (da) * | 2001-10-26 | 2006-06-12 | Angeletti P Ist Richerche Bio | N-substituerede hydroxypyrimidinon-carboxamid-inhibitorer af HIV-integrase |
US7071213B2 (en) | 2001-11-14 | 2006-07-04 | Schering Corporation | Cannabinoid receptor ligands |
EP1463741A4 (en) * | 2001-12-07 | 2006-07-05 | Us Gov Health & Human Serv | COMPOUNDS FOR THE TREATMENT OF HIV INFECTION AND AIDS |
US20030236277A1 (en) | 2002-02-14 | 2003-12-25 | Kadow John F. | Indole, azaindole and related heterocyclic pyrrolidine derivatives |
US7217732B2 (en) | 2002-06-19 | 2007-05-15 | Schering Corporation | Cannabinoid receptor agonists |
US7176232B2 (en) | 2002-06-24 | 2007-02-13 | The Regents Of The University Of California | Salinosporamides and methods for use thereof |
CN100540548C (zh) * | 2002-08-02 | 2009-09-16 | 尼瑞斯药品公司 | 脱氢苯基阿夕斯丁及其类似物以及脱氢苯基阿夕斯丁及其类似物的合成 |
US7919497B2 (en) * | 2002-08-02 | 2011-04-05 | Nereus Pharmaceuticals, Inc. | Analogs of dehydrophenylahistins and their therapeutic use |
US7935704B2 (en) * | 2003-08-01 | 2011-05-03 | Nereus Pharmaceuticals, Inc. | Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
JP3908248B2 (ja) | 2002-08-13 | 2007-04-25 | 塩野義製薬株式会社 | Hivインテグラーゼ阻害活性を有するヘテロ環化合物 |
WO2004034970A2 (en) * | 2002-09-27 | 2004-04-29 | Nereus Pharmaceuticals, Inc. | Macrocyclic lactams |
AR043633A1 (es) | 2003-03-20 | 2005-08-03 | Schering Corp | Ligandos de receptores de canabinoides |
CN1823070A (zh) * | 2003-06-20 | 2006-08-23 | 加利福尼亚大学董事会 | 盐孢菌酰胺及其使用方法 |
NZ544588A (en) * | 2003-06-20 | 2010-06-25 | Nereus Pharmaceuticals Inc | Use of salinosporamide A and analogs thereof for the treatment of cancer, inflammation and infectious diseases |
AU2005206560A1 (en) * | 2004-01-23 | 2005-08-04 | Nereus Pharmaceuticals, Inc. | Bis-indole pyrroles useful as antimicrobials agents |
EP1730135B1 (en) | 2004-03-10 | 2010-09-22 | The United States of America, represented by the Secretary, Department of Health and Human Services | Qiunolin-4-ones as inhibitors of retroviral integrase for the treatment of hiv, aids and aids related complex (arc) |
AU2005283141B2 (en) * | 2004-04-30 | 2012-05-10 | Nereus Pharmaceuticals, Inc. | (3.2.0) heterocyclic compounds and methods of using the same |
US7579371B2 (en) | 2004-04-30 | 2009-08-25 | Nereus Pharmaceuticals, Inc. | Methods of using [3.2.0] heterocyclic compounds and analogs thereof |
BRPI0515344A (pt) * | 2004-09-17 | 2008-07-15 | Idenix Pharmaceuticals Inc | composto, composição farmacêutica, e, usos de uma quantidade eficaz de um composto 3-fosfoindol ou sal, pró-droga, estereoisÈmero, tautÈmero, n-óxido ou amina quaternária farmaceuticamente aceitável do mesmo e de uma quantidade de tratamento eficaz anti-hiv de um composto de 3-fosfoindol ou sal, pró-droga, estereo-isÈmero, tautÈmero, n-óxido ou amina quaternária farmaceuticamente aceitável do mesmo |
US20060100432A1 (en) | 2004-11-09 | 2006-05-11 | Matiskella John D | Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione |
PL1830838T3 (pl) * | 2004-12-03 | 2013-07-31 | Dana Farber Cancer Inst Inc | Kompozycje i sposoby leczenia chorób neoplastycznych |
CN1316968C (zh) * | 2005-09-30 | 2007-05-23 | 青岛大学 | 吲哚-2,3-二酮在制备抗病毒或免疫增强剂药物中的应用 |
US7851476B2 (en) | 2005-12-14 | 2010-12-14 | Bristol-Myers Squibb Company | Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine |
KR20080114711A (ko) * | 2006-03-02 | 2008-12-31 | 아스텔라스세이야쿠 가부시키가이샤 | 17β HSD 타입 5 저해제 |
GB2450268B (en) * | 2006-03-17 | 2011-01-12 | Cipla Ltd | Synthesis of 4-[1-(4-cyano phenyl)-1-(1,2,4-triazol-1-yl)methyl]benzonitrile and 4-[1-(1,2,4-triazol-1-yl)methyl]benzonitrile intermediate |
KR20080109071A (ko) | 2006-04-06 | 2008-12-16 | 니리어스 파마슈티컬즈, 인코퍼레이션 | 살리노스포라마이드 a 및 그의 유도체들의 전합성 |
US7807671B2 (en) | 2006-04-25 | 2010-10-05 | Bristol-Myers Squibb Company | Diketo-piperazine and piperidine derivatives as antiviral agents |
BRPI0717511A2 (pt) * | 2006-09-29 | 2013-11-19 | Idenix Pharmaceuticals Inc | Composto puro, composição farmacêutica, métodos para tratar uma infecção por hiv, para prevenir uma infecção por hiv, para inibir a replicação de hiv, e, uso de um composto |
US8129527B2 (en) * | 2006-11-03 | 2012-03-06 | Nereus Pharmacuticals, Inc. | Analogs of dehydrophenylahistins and their therapeutic use |
US7824698B2 (en) * | 2007-02-02 | 2010-11-02 | Nereus Pharmaceuticals, Inc. | Lyophilized formulations of Salinosporamide A |
US8394816B2 (en) * | 2007-12-07 | 2013-03-12 | Irene Ghobrial | Methods of using [3.2.0] heterocyclic compounds and analogs thereof in treating Waldenstrom's Macroglobulinemia |
EP2543368A1 (en) | 2007-12-11 | 2013-01-09 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties |
EP2276765A4 (en) * | 2008-05-12 | 2011-10-19 | Nereus Pharmaceuticals Inc | SALINOSPORAMIDE DERIVATIVES AS PROTEASOMAL HEMMER |
WO2013123658A1 (en) | 2012-02-23 | 2013-08-29 | Empire Technology Development Llc | Azobenzene compounds with cholesterol group and their sunscreen compositions |
CN103420894A (zh) * | 2012-05-22 | 2013-12-04 | 中国科学院上海药物研究所 | 丁-2-烯-1,4-二酮类化合物及其制备方法和用途 |
RU2020116666A (ru) | 2014-09-14 | 2020-07-31 | Аванир Фармасьютикалз, Инк. | Фармацевтические композиции, содержащие декстрометорфановое соединение и хинидин для лечения возбуждения при деменции |
RU2728796C2 (ru) | 2015-03-06 | 2020-07-31 | Бейондспринг Фармасьютикалс, Инк. | Способ лечения опухоли головного мозга |
CN107530341B (zh) | 2015-03-06 | 2021-10-01 | 大连万春布林医药有限公司 | 治疗与ras突变相关的癌症的方法 |
SG10202108194XA (en) | 2015-07-13 | 2021-09-29 | Beyondspring Pharmaceuticals Inc | Plinabulin compositions |
CA3013467A1 (en) | 2016-02-08 | 2017-08-17 | Beyondspring Pharmaceuticals, Inc. | Compositions containing tucaresol or its analogs |
BR112018074990A2 (pt) | 2016-06-06 | 2019-03-12 | Beyondspring Pharmaceuticals, Inc. | composição, usos e método para reduzir neutropenia |
US11633393B2 (en) | 2017-01-06 | 2023-04-25 | Beyondspring Pharmaceuticals, Inc. | Tubulin binding compounds and therapeutic use thereof |
EP3576733A4 (en) | 2017-02-01 | 2020-11-25 | Beyondspring Pharmaceuticals, Inc. | METHOD OF REDUCING NEUTROPENIA |
CN106995400B (zh) * | 2017-04-10 | 2019-08-06 | 湘潭大学 | 一种化合物及其盐及其合成方法 |
CN107226810B (zh) * | 2017-06-16 | 2020-04-28 | 郑州大学 | 吲哚衍生物及其制备方法和其抗流感病毒作用 |
WO2019147615A1 (en) | 2018-01-24 | 2019-08-01 | Beyondspring Pharmaceuticals, Inc. | Composition and method for reducing thrombocytopenia via the administration of plinabulin |
CN109810044B (zh) * | 2019-02-27 | 2022-05-03 | 贵州医科大学 | 一种具有hiv-1整合酶抑制活性的化合物及其制备和应用 |
WO2023115203A1 (en) * | 2021-12-20 | 2023-06-29 | Fairhaven Pharmaceuticals Inc. | Oxer1 antagonists and uses thereof |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4377698A (en) * | 1976-01-22 | 1983-03-22 | Sterling Drug Inc. | 2,4 Bis(2-indolyl-3)-4-oxobutanoic acids |
WO1993005020A1 (en) * | 1991-09-06 | 1993-03-18 | Merck & Co., Inc. | Indoles as inhibitors of hiv reverse transcriptase |
US5475109A (en) | 1994-10-17 | 1995-12-12 | Merck & Co., Inc. | Dioxobutanoic acid derivatives as inhibitors of influenza endonuclease |
US6069156A (en) * | 1995-04-10 | 2000-05-30 | Fujisawa Pharmaceutical Co., Ltd. | Indole derivatives as cGMP-PDE inhibitors |
US5858738A (en) * | 1996-11-07 | 1999-01-12 | Merck & Co., Inc. | Ermophilane sesquiterpenoids as HIV intergrase inhibitors |
AU752005B2 (en) * | 1998-03-26 | 2002-09-05 | Shionogi & Co., Ltd. | Indole derivatives with antiviral activity |
AU756826C (en) | 1998-06-03 | 2003-08-21 | Merck & Co., Inc. | HIV integrase inhibitors |
CA2333771A1 (en) | 1998-06-03 | 1999-12-09 | Mark W. Embrey | Hiv integrase inhibitors |
EP1082121A4 (en) | 1998-06-03 | 2003-02-05 | Merck & Co Inc | INTEGRASE HIV INHIBITORS |
EP1196384A4 (en) | 1999-06-25 | 2002-10-23 | Merck & Co Inc | 1- (AROMATIC OR HETEROAROMATICALLY SUBSTITUTED) -3- (HETEROAROMATICALLY SUBSTITUTED) -1,3-PROPANDIONS AND THEIR APPLICATIONS |
-
1999
- 1999-03-26 AU AU29581/99A patent/AU752005B2/en not_active Ceased
- 1999-03-26 NZ NZ506435A patent/NZ506435A/xx unknown
- 1999-03-26 BR BR9909146-1A patent/BR9909146A/pt not_active IP Right Cessation
- 1999-03-26 JP JP2000541150A patent/JP3794469B2/ja not_active Expired - Fee Related
- 1999-03-26 RU RU2000126474/04A patent/RU2217421C2/ru not_active IP Right Cessation
- 1999-03-26 CN CNB998044180A patent/CN1142909C/zh not_active Expired - Fee Related
- 1999-03-26 IL IL13797499A patent/IL137974A0/xx unknown
- 1999-03-26 ID IDW20001898A patent/ID26031A/id unknown
- 1999-03-26 US US09/622,543 patent/US6333323B1/en not_active Expired - Fee Related
- 1999-03-26 CA CA002326166A patent/CA2326166A1/en not_active Abandoned
- 1999-03-26 HU HU0103460A patent/HUP0103460A3/hu unknown
- 1999-03-26 PL PL99343249A patent/PL343249A1/xx unknown
- 1999-03-26 KR KR1020007009926A patent/KR20010041705A/ko not_active Application Discontinuation
- 1999-03-26 WO PCT/JP1999/001547 patent/WO1999050245A1/ja not_active Application Discontinuation
- 1999-03-26 EP EP99910719A patent/EP1069111A4/en not_active Withdrawn
-
2000
- 2000-08-08 ZA ZA200004047A patent/ZA200004047B/xx unknown
- 2000-09-25 NO NO20004787A patent/NO317423B1/no not_active IP Right Cessation
-
2001
- 2001-08-15 US US09/929,486 patent/US6506787B2/en not_active Expired - Fee Related
-
2002
- 2002-09-30 US US10/259,903 patent/US6716605B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
RU2217421C2 (ru) | 2003-11-27 |
JP3794469B2 (ja) | 2006-07-05 |
BR9909146A (pt) | 2000-12-05 |
US20020019434A1 (en) | 2002-02-14 |
IL137974A0 (en) | 2001-10-31 |
ZA200004047B (en) | 2001-04-25 |
ID26031A (id) | 2000-11-16 |
KR20010041705A (ko) | 2001-05-25 |
NZ506435A (en) | 2002-08-28 |
EP1069111A4 (en) | 2001-06-06 |
AU2958199A (en) | 1999-10-18 |
WO1999050245A1 (fr) | 1999-10-07 |
CN1142909C (zh) | 2004-03-24 |
US6716605B2 (en) | 2004-04-06 |
US20030181499A1 (en) | 2003-09-25 |
NO317423B1 (no) | 2004-10-25 |
US6333323B1 (en) | 2001-12-25 |
CN1294580A (zh) | 2001-05-09 |
AU752005B2 (en) | 2002-09-05 |
US6506787B2 (en) | 2003-01-14 |
EP1069111A1 (en) | 2001-01-17 |
HUP0103460A3 (en) | 2002-11-28 |
PL343249A1 (en) | 2001-07-30 |
NO20004787D0 (no) | 2000-09-25 |
CA2326166A1 (en) | 1999-10-07 |
NO20004787L (no) | 2000-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0103460A2 (hu) | Vírusellenes hatású indolszármazékok és a vegyületeket tartalmazó gyógyszerkészítmények | |
HUP0201472A2 (hu) | HIV-integráz ellen gátló hatású heteroaromás származékok | |
TR199902606T2 (xx) | Farnesil transferaz� engelleyici kinazolinonlar. | |
HUP0400636A2 (hu) | Azetidinszármazékokat tartalmazó gyógyszerkészítmények, új azetidinszármazékok és előállításuk | |
RU95101048A (ru) | Производные пролинамида, фармкомпозиция на их основе | |
HUP0101999A2 (hu) | 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása | |
TR199800720T2 (xx) | Farnesil transferaz inhibe eden 2-kinolon t�revleri. | |
HUP0100156A2 (hu) | Foszfolipáz-A2 inhibitor hatású indolszármazékok és alkalmazásuk gyógyászati készítmények előállítására | |
HUP0301195A2 (hu) | Alfa-4 integrin antagonista hatású aza-hidas biciklusos aminosav-származékok és ilyen vegyületeket tartalmazó gyógyszerkészítmények | |
PL396946A1 (pl) | Pochodne pirazolu i kompozycje farmaceutyczne zawierające je oraz ich zastosowanie do leczenia HIV | |
HUP0002353A2 (hu) | IV típusú foszfodiészteráz inhibitor hatású 1-cikloalkil-1,8-naftiridin-4-on-származékok és ezeket a vegyületeket tartalmazó gyógyszerkészítmények | |
HUP0101530A2 (hu) | Daganatellenes hatású indol-3-il-glioxilsav-származékokat tartalmazó gyógyszerkészítmények | |
NO20044731L (no) | Kinolin- og isokinolinderivater fremgangsmate for fremstilling derav og anvendelse derav som betennelseshemmere | |
HUP0400579A2 (hu) | Tetralonszármazékok mint tumorellenes gyógyászati hatóanyagok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
DK0948527T3 (da) | Cylosporinderivater, fremstilling af disse og farmaceutiske præparater indeholdende disse | |
HUP0402019A2 (hu) | CCR5 antagonistaként alkalmazható piperidinszármazékok és ezeket tartalmazó gyógyszerkészítmények | |
ATE300541T1 (de) | Pyrazolopyridinderivate | |
TR200002605T2 (tr) | Nitrik oksit sentaz inhibitörleri olarak faydalı halojene amidino amino asit türevleri | |
HUP0203054A2 (hu) | Farnezil protein transzferáz inhibitorok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
HUP0100865A2 (hu) | Meta-azaciklusos csoporttal N-szubsztituált amino-benzoesav-vegyületek és származékaik mint integrin antagonista hatóanyagok, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk | |
TR199900732T2 (xx) | PDE IV inhibe eden 2-siyanoiminoimidazol t�revleri. | |
MA22895A1 (fr) | 7-(2-aminoethyl) benzothiazolones. | |
HUP9700005A2 (hu) | 2-Ureido-benzamid-származékok és ilyeneket hatóanyagként tartalmazó gyógyszerkészítmények | |
SE0200919D0 (sv) | Chemical compounds | |
DE60318874D1 (en) | Pyrazolderivate |